The underestimated risk of additional ipsilateral BI-RADS 3 lesions identified by preoperative ultrasound in breast cancer patients
To determine the prevalence of malignancy of additional ultrasound BI-RADS category 3 lesions in women with newly diagnosed breast cancer. Between July 2014 and June 2022, women with newly diagnosed breast cancer and additional ultrasound BI-RADS 3 lesions were retrospectively included. Malignancy was confirmed by path...